The glucagonoma syndrome is associated with loss ofbody weight and decreased concentrations of blood amino acids.' In normal man, hyperglucagonaemia reduces the amino acid concentration,23 but despite this urea synthesis is increased.2 3 In rats, glucagon increases the hepatic uptake of amino acids4 and the rate of urea synthesis resulting in loss of organ nitrogen.5 This suggests that the decreased blood amino acid concentrations may be caused by increased hepatic clearance and conversion of amino acids to urea. Moreover, it suggests that the loss of body weight seen in the glucagonoma syndrome represents loss of body protein, and that this is secondary to the increased hepatic conversion of amino acids to urea. In man, the total protein content can be assessed by determination of the lean body mass. 6 We have studied clearance of amino acids, rate ofurea synthesis, and lean body mass in a patient with a glucagonoma.
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Case report
The patient is a 52 year old woman (weight 52 kg, height 172 cm) suffering from non-specific skin lesions (pruritus and vesicles on the hands).
One year before the present investigation, increased urinary excretion of 5 hydroxyindoleacetic acid was found. Ultrasound showed multiple focal liver lesions in both lobes, but no primary tumor, and especially no lesions of the pancreas, were found. Liver biopsy specimen histology suggested a neuroendocrine tumor, and immunohistochemistry showed glucagonoma.
The plasma concentrations of glucagon were considerably raised (1500-1600 pmol/l; normal range 15-45 pmol/l) and high concentrations of pancreatic polypeptide were also found. The concentrations of gastrin vasoactive intestinal polypeptide, somatostatin, secretin, and calcitonin were within the normal range.
Since diagnosis the patient has been treated with repeated courses of streptozotocin. Since then there has been a decrease in the plasma glucagon concentrations (to 380 pmol/l at the time of investigation).
Methods
The investigative procedure has already been described in detail.7 After an overnight fast blood samples were drawn for determination of fasting concentrations of plasma amino acids, total blood a amino-nitrogen, blood urea, blood glucose, plasma pancreatic glucagon, and insulin. An amino acid mixture (Intrafusin 10%, Pfrimmer and Co, W Germany) was given as a two step intravenous infusion, firstly at a constant rate of 41 The individual amino acid concentrations were determined by ion chromatography followed by postcolumn derivatisation with orthopthaldehyde and fluorescent detection, total blood a aminonitrogen values were determined by the dinitrofluorobenzene method,'2 urea in blood and urine by the urease-Berthelot method,'3 blood glucose by enzymatic analysis, '4 and plasma insulin and pancreatic glucagon by radioimmunoassay techniques.5 16 The individual results for the patient are given together with the normal range, stated as the 95% confidence limits of normal individuals derived from,7 in parenethesis.
Results
Fasting blood glucose was 8-3 mmol/l (normal range 4 0-5 0 mmol/1), fasting glucagon was 380 pmol/l (normal range 15-45 pmol/l), and fasting insulin was 11 mU/l (normal range 5-7 mU/l). Fasting blood concentrations of all amino acids were reduced (Table I) . Amino acid infusion raised the concentration of total a aminonitrogen to an average of 2-2 mmol/l (normal range 4 7-5 5 mmol/l). The urea nitrogen synthesis rate during amino acid infusion was increased to 27 ,umol/kg per minute (normal range 20-24 imol/kg per minute). The clearances of all amino acids were increased apart from those of glutamine+ glutamate, histidine, phenylalanine, and valine (Table II) .
The body weight (52 kg) of the patient was 79% ofthe expected value, whereas the lean body mass was 59% of the expected value.
Discussion
This study confirms previous observations of decreased amino acid concentrations in patients with the glucagonoma syndrome.' '7 It shows that this is probably caused by an increased clearance of amino acids. The most noticeable changes were seen in the gluconeo-and ureagenic amino acids: alanine, glycine, methoinine, proline, and serine. Since glucagon does not increase muscular uptake of amino acids2 but increases urea synthesis,23 the increased clearance is probably the result of increased hepatic uptake and conversion, and this is also indicated by the increased rate of urea synthesis.
Infusion of amino acids raised the total amino acid concentration to 2-2 mmol/l, which is less than 50% of the value reached in normal people.7 Despite this, the rate of urea synthesis was increased in the patient. This is in accordance with studies in rats, where chronic hyperglucagonaemia reduced the amino acid concentration but increased the rate of urea synthesis, resulting in loss of nitrogen from organ proteins.5
Both the total body weight and the lean body mass were reduced in the patient, but the latter was reduced to a much greater extent suggesting that most of the weight loss in patients with glucagonoma syndrome is accounted for by loss of organ proteins.
It is therefore possible that the weight loss of patients with glucagonoma syndrome is due to an increased hepatic clearance and conversion of amino-N to urea-N leading to reduced amino acid concentrations, and organ protein catabolism.
This observation supports the hypothesis that changes in hepatic conversion of amino acids may regulate actively the rate of catabolism in organs. '8 Our thanks to Dr J J Holst, Department of Medical Physiology C, University of Copenhagen, for the initial diagnostic determination of glucagon concentration.
